Drugs / mix of AllerT1-T2-T3
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01719133 | Feb → Mar 2008 | allergic rhinitis | Anergis | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mix of AllerT1-T2-T3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01719133 ↗ |
| Modality | Peptide | “mix of peptides T1, T2 and T3” NCT01719133 ↗ |
| Route | Other | “all by skin tests” NCT01719133 ↗ |